POLYMED — Poly Medicure Share Price
0.000.00%
Last trade - 00:00- IN₹256.82bn
- IN₹245.78bn
- IN₹13.76bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 61.32 | ||
| PEG Ratio (f) | 2.95 | ||
| EPS Growth (f) | 26.27% | ||
| Dividend Yield (f) | 0.25% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.91 | ||
| Price to Tang. Book | 10.13 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 15.98 | ||
| EV to EBITDA | 57.11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.36% | ||
| Return on Equity | 16.04% | ||
| Operating Margin | 21.91% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 6,872.39 | 7,864.7 | 9,230.63 | 11,152.3 | 13,757.96 | 16,893.33 | 20,691.67 | 17.63% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +47.61 | +40.41 | -0.09 | +22.58 | +42.76 | +22.86 | +26.27 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.
Directors
- Devendra Mehta NEC (84)
- Naresh Vijayvargiya CFO
- Vishal Baid CEX
- Deepak Gupta SVP
- Vinay Gujral CCO
- V. Khera VOP
- Himanshu Baid MDR (46)
- Rishi Baid EDR (42)
- Hemant Bhalla OTH
- Avinash Chandra SEC
- Alessandro Balboni DRC
- Jugal Baid NED (72)
- Mukulika Baid NED (65)
- Sandeep Bhargava NED
- Amit Khosla NED
- Sonal Mattoo NID
- Shailendra Mehta NID (56)
- Prakash Surana NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 30th, 1995
- Public Since
- December 5th, 2011
- No. of Shareholders
- 36,712
- No. of Employees
- 2,651
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 101,325,715
- Address
- Plot No.104-105 & 115-116 , Sector-59,, FARIDABAD, 121004
- Web
- https://www.polymedicure.com/
- Phone
- +91 1292307000
- Contact
- Avinash Chandra
- Auditors
- MC Bhandari & Co
Upcoming Events for POLYMED
Q1 2026 Poly Medicure Ltd Earnings Release
Poly Medicure Ltd Annual Shareholders Meeting
Similar to POLYMED
Borosil Scientific
National Stock Exchange of India
Entero Healthcare Solutions
National Stock Exchange of India
HVAX Technologies
National Stock Exchange of India
Laxmi Dental
National Stock Exchange of India
Mohini Health & Hygiene
National Stock Exchange of India
FAQ
What is the Poly Medicure share price?
As of Today at 04:41 UTC, shares in Poly Medicure are trading at IN₹2,534.60. This share price information is delayed by 15 minutes.
How has the Poly Medicure share price performed this year?
Shares in Poly Medicure last closed at IN₹2,534.60 and the price had moved by +60.01% over the past 365 days. In terms of relative price strength the Poly Medicure share price has outperformed the S&P BSE 100 Index by +50.73% over the past year.
What are the analyst and broker recommendations for Poly Medicure?
The overall consensus recommendation for Poly Medicure is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Poly Medicure dividend yield?
The Poly Medicure dividend yield is 0.12% based on the trailing twelve month period.
Does Poly Medicure pay a dividend?
Last year, Poly Medicure paid a total dividend of IN₹3.00, and it currently has a trailing dividend yield of 0.12%. We do not have any data on when Poly Medicure is to next pay dividends.
When does Poly Medicure next pay dividends?
We do not have data on when Poly Medicure is to next pay dividends. The historic dividend yield on Poly Medicure shares is currently 0.12%.
How do I buy Poly Medicure shares?
To buy shares in Poly Medicure you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Poly Medicure?
As of the previous close price of IN₹2,534.60, shares in Poly Medicure had a market capitalisation of IN₹256.82bn.
Where are Poly Medicure shares listed?
Here are the trading details for Poly Medicure:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: POLYMED
What kind of share is Poly Medicure?
Based on an overall assessment of its quality, value and momentum Poly Medicure is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Poly Medicure share price forecast for 2025?
The analyst consensus target price for shares in Poly Medicure is IN₹2,339.00. That is 7.72% below the last closing price of IN₹2,534.60.
Analysts covering Poly Medicure currently have a consensus Earnings Per Share (EPS) forecast of IN₹32.73 for the next financial year.
Find out moreWhat is the trend in the Poly Medicure share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Poly Medicure. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +2.95%.
As of the last closing price of IN₹2,534.60, shares in Poly Medicure were trading +6.06% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Poly Medicure PE Ratio?
The Poly Medicure PE ratio based on its reported earnings over the past 12 months is 61.32. The shares last closed at IN₹2,534.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Poly Medicure?
Poly Medicure's management team is headed by:
- Devendra Mehta - NEC
- Naresh Vijayvargiya - CFO
- Vishal Baid - CEX
- Deepak Gupta - SVP
- Vinay Gujral - CCO
- V. Khera - VOP
- Himanshu Baid - MDR
- Rishi Baid - EDR
- Hemant Bhalla - OTH
- Avinash Chandra - SEC
- Alessandro Balboni - DRC
- Jugal Baid - NED
- Mukulika Baid - NED
- Sandeep Bhargava - NED
- Amit Khosla - NED
- Sonal Mattoo - NID
- Shailendra Mehta - NID
- Prakash Surana - NID